ClinicalTrials.Veeva

Menu

Salivary C- Reactive Protein, Mean Platelet Volume and Neutrophil Lymphocyte Ratio as Diagnostic Markers for Neonatal Sepsis

Cairo University (CU) logo

Cairo University (CU)

Status

Unknown

Conditions

Neonatal Sepsis

Treatments

Diagnostic Test: Salivary CRP

Study type

Observational

Funder types

Other

Identifiers

NCT04800445
MS-53-2020

Details and patient eligibility

About

To evaluate reliability of salivary C-reactive protein ,mean platelet volume , neutrophil -lymphocyte ratio , and platelet lymphocyte ratio in diagnosis of neonatal sepsis

Enrollment

80 patients

Sex

All

Ages

1 to 28 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

    • Full term neonates of both genders from birth to the 28th day of life diagnosed with sepsis by history, clinical findings, laboratory findings, and blood culture. The clinical findings included the presence of three or more of the following:
  • (1) temperature instability (hypothermia, hyperthermia) .
  • (2) respiratory alterations (grunting, intercostal retractions, apnea, tachypnea, cyanosis) .
  • (3) cardiovascular alterations (bradycardia, tachycardia, poor perfusion, hypotension) .
  • (4) neurologic alterations (hypotonia, lethargy, seizures)
  • (5) gastrointestinal alterations (feeding intolerance, abdominal distension). CRP values >10 mg/L were considered to be positive.

Exclusion criteria

    • Preterm neonates .
  • Neonates with CNS malformations, metabolic disorders, chromosomal abnormalities, intrauterine growth restriction, or birth asphyxia were excluded from the study

Trial design

80 participants in 2 patient groups

Case group of fullterm neonates with neonatal sepsis
Treatment:
Diagnostic Test: Salivary CRP
Healthy fullterm neonates
Treatment:
Diagnostic Test: Salivary CRP

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems